FSN Co., Ltd. (KOSDAQ:A214270), AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. (KOSDAQ:A065650) from Hansung Cleantech Co., Ltd. (KOSDAQ:A066980) and T Scientific Co.,Ltd. (KOSDAQ:A057680) for KRW21.7 billion on February 16, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,285 KRW | -1.30% | +8.04% | -16.45% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,285 KRW | -1.30% | +8.04% | 54.9M | ||
1,206 KRW | +1.26% | +3.61% | 59.71M | ||
1st Jan change | Capi. | |
---|---|---|
-16.45% | 54.9M | |
+16.31% | 6.98B | |
-12.28% | 1.87B | |
-4.50% | 1.28B | |
-13.30% | 1.12B | |
-36.65% | 606M | |
-6.90% | 516M | |
-33.86% | 483M | |
+9.42% | 434M | |
-31.56% | 382M |
- Stock Market
- Equities
- A214270 Stock
- News FSN Co., Ltd.
- FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd. for KRW21.7 billion.